Patient Outcomes
24 stories
‘Implementing Artificial Intelligence in Rheumatoid Arthritis Care: A Collaboration with S Louis Bridges Jr, MD, PhD’
The integration of artificial intelligence (AI) in rheumatoid arthritis (RA) management presents a vast potential for improving patient care, S Louis Bridges Jr, MD, PhD, professor…
Evaluating the Effectiveness of Adalimumab Biosimilars for Inflammatory Disorders
This is a video synopsis/summary of a panel discussion involving Jamie T. Brogan, MSN, APRN, FNP-BC; Kostas Botsoglou, MD; Jordan Axelrad, MD, MPH; Sophia Humphreys, PharmD,…
The importance of pharmacists in RSV vaccination: Collaborative clinical decision making and education
Pharmacists are crucial in the decision-making process for respiratory syncytial virus (RSV) vaccination and in educating patients about its importance, especially among older…
High-Risk Factors Linked to Cardiac Toxicities in Lung Cancer by Dr. Amini
Arya Amini, MD, radiation oncologist, associate professor, Department of Radiation Oncology, chief, Thoracic Radiotherapy, City of Hope, discusses cardiac toxicities associated with lung cancer. As……
Treatment Decision-Making in Renal Cell Carcinoma by Dr. Xu
Wenxin (Vincent) Xu, MD, physician, Dana-Farber Cancer Institute, assistant professor, medicine, Harvard Medical School, discusses treatment decision-making for patients with renal cell carcinoma……
Understanding Step Edits for Patients Recently Diagnosed with nAMD
This is a video synopsis of a discussion involving Ehsan Rahimy, MD, a retina specialist at the Palo Alto Medical Foundation and adjunct faculty at Stanford…
Safety and Feasibility of Robotic Surgery for Gallbladder Cancer
WEDNESDAY, March 20, 2024 (HealthDay News) — For patients undergoing gallbladder cancer surgery, robotic-assisted surgery has comparable oncological outcomes to open surgery, according to a review……
Treatment of Advanced HCC with Durvalumab and Tremelimumab: Patient Case Study
AI Models May Serve As Additional Genetic Counseling Resource in……
Partnership formed to support oncology care clinicians in Flatiron Health’s collaboration with MUSC
Flatiron Assist has over 700 oncologist users and has been leveraged in over 90k treatment decisions Flatiron Health is a healthcare technology and services company focused on accelerating cancer…
The Progress of ADCs in HR+/HER2+ and HER2-Low Breast Cancer
Hope Rugo, MD, Winterhof Family Endowed Professor in Breast Cancer, the University of California San Francisco (UCSF), professor, medicine, Department of Medicine (Hematology/Oncology), Division of……